Catabasis Pharmaceuticals, Inc.

Release Summary

Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, today announced the publication of preclinical data on the edasalonexent program.

Catabasis Pharmaceuticals, Inc.